|
|
|
Volumn 56, Issue 12, 2001, Pages 963-966
|
|
Intranasal administration of midazolam in a cyclodextrin based formulation: Bioavailability and clinical evaluation in humans
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA CYCLODEXTRIN SULFOBUTYL ETHER;
BUFFER;
MIDAZOLAM;
MIDAZOLAM MALEATE;
ADULT;
AQUEOUS SOLUTION;
ARTICLE;
CLINICAL OBSERVATION;
CLINICAL TRIAL;
CONCENTRATION RESPONSE;
CROSSOVER PROCEDURE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
DRUG FORMULATION;
EVALUATION;
FEMALE;
HUMAN;
HUMAN EXPERIMENT;
MALE;
NORMAL HUMAN;
NOSE IRRITATION;
PH;
PHARYNX;
RELIABILITY;
SEDATION;
SIDE EFFECT;
ADMINISTRATION, INTRANASAL;
ADULT;
AEROSOLS;
BIOLOGICAL AVAILABILITY;
CYCLODEXTRINS;
EXCIPIENTS;
FEMALE;
HUMANS;
HYPNOTICS AND SEDATIVES;
INDICATORS AND REAGENTS;
INJECTIONS, INTRAVENOUS;
IRRITANTS;
MALE;
MICROSCOPY, ELECTRON, SCANNING;
MIDAZOLAM;
|
|
EID: 0035663585
PISSN: 00317144
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (49)
|
|
References (40)
|
